Federation des caisses Desjardins du Quebec’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.9M | Buy |
31,948
+12,367
| +63% | +$2.37M | 0.02% | 438 |
|
|
2026
Q1 | $3.59M | Buy |
19,581
+7,233
| +59% | +$1.33M | 0.01% | 558 |
|
|
2025
Q4 | $2.17M | Buy |
12,348
+1,773
| +17% | +$290K | 0.01% | 701 |
|
|
2025
Q3 | $1.48M | Buy |
10,575
+431
| +4% | +$58.3K | 0.01% | 811 |
|
|
2025
Q2 | $1.27M | Sell |
10,144
-599
| -6% | -$74.6K | 0.01% | 787 |
|
|
2025
Q1 | $1.47M | Sell |
10,743
-653
| -6% | -$93.3K | 0.01% | 715 |
|
|
2024
Q4 | $1.74M | Buy |
11,396
+1,292
| +13% | +$218K | 0.01% | 626 |
|
|
2024
Q3 | $1.96M | Buy |
10,104
+998
| +11% | +$209K | 0.01% | 590 |
|
|
2024
Q2 | $2.11M | Sell |
9,106
-2,849
| -24% | -$619K | 0.01% | 548 |
|
|
2024
Q1 | $2.76M | Buy |
11,955
+1,350
| +13% | +$316K | 0.02% | 444 |
|
|
2023
Q4 | $2.74M | Sell |
10,605
-5,924
| -36% | -$1.46M | 0.03% | 381 |
|
|
2023
Q3 | $4.25M | Sell |
16,529
-1,336
| -7% | -$357K | 0.04% | 285 |
|
|
2023
Q2 | $5.09M | Buy |
17,865
+6,121
| +52% | +$1.82M | 0.05% | 270 |
|
|
2023
Q1 | $3.27M | Buy |
11,744
+1,662
| +16% | +$460K | 0.04% | 300 |
|
|
2022
Q4 | $2.79M | Sell |
10,082
-46
| -0.5% | -$13K | 0.03% | 316 |
|
|
2022
Q3 | $2.7M | Sell |
10,128
-3,351
| -25% | -$712K | 0.03% | 337 |
|
|
2022
Q2 | $2.75M | Buy |
13,479
+249
| +2% | +$50.9K | 0.03% | 337 |
|
|
2022
Q1 | $2.79M | Sell |
13,230
-131
| -1% | -$28.5K | 0.03% | 365 |
|
|
2021
Q4 | $3.21M | Sell |
13,361
-157
| -1% | -$40.4K | 0.03% | 341 |
|
|
2021
Q3 | $3.82M | Sell |
13,518
-373
| -3% | -$122K | 0.04% | 312 |
|
|
2021
Q2 | $4.81M | Sell |
13,891
-3,404
| -20% | -$1.03M | 0.05% | 289 |
|
|
2021
Q1 | $4.84M | Sell |
17,295
-3,082
| -15% | -$831K | 0.05% | 273 |
|
|
2020
Q4 | $4.99M | Buy |
20,377
+9,265
| +83% | +$2.39M | 0.06% | 260 |
|
|
2020
Q3 | $3.15M | Buy |
11,112
+318
| +3% | +$88.7K | 0.04% | 303 |
|
|
2020
Q2 | $2.89M | Buy |
10,794
+291
| +3% | +$87.5K | 0.04% | 301 |
|
|
2020
Q1 | $3.32M | Sell |
10,503
-4,838
| -32% | -$1.47M | 0.06% | 240 |
|
|
2019
Q4 | $4.55M | Buy |
15,341
+739
| +5% | +$205K | 0.06% | 237 |
|
|
2019
Q3 | $3.4M | Buy |
14,602
+7,907
| +118% | +$1.84M | 0.05% | 285 |
|
|
2019
Q2 | $1.57M | Sell |
6,695
-161
| -2% | -$37.2K | 0.02% | 501 |
|
|
2019
Q1 | $1.62M | Sell |
6,856
-283
| -4% | -$89.1K | 0.02% | 466 |
|
|
2018
Q4 | $2.15M | Sell |
7,139
-2,719
| -28% | -$868K | 0.04% | 379 |
|
|
2018
Q3 | $3.48M | Buy |
9,858
+1,038
| +12% | +$357K | 0.05% | 297 |
|
|
2018
Q2 | $2.56M | Buy |
8,820
+212
| +2% | +$59.6K | 0.04% | 370 |
|
|
2018
Q1 | $2.36M | Sell |
8,608
-544
| -6% | -$169K | 0.04% | 394 |
|
|
2017
Q4 | $2.92M | Buy |
9,152
+423
| +5% | +$136K | 0.04% | 330 |
|
|
2017
Q3 | $2.73M | Sell |
8,729
-458
| -5% | -$136K | 0.04% | 332 |
|
|
2017
Q2 | $2.49M | Buy |
9,187
+576
| +7% | +$152K | 0.04% | 354 |
|
|
2017
Q1 | $2.35M | Buy |
+8,611
| New | +$2.43M | 0.04% | 330 |
|
Other funds holding BIIB
Federation des caisses Desjardins du Quebec's BIIB Position: Q2 2026 in Review
Federation des caisses Desjardins du Quebec increased its Biogen (BIIB) stake by 63% in Q2 2026, buying an estimated $2.37M and bringing the position to 31,948 shares worth $6.9M. The position accounts for 0.02% of the portfolio, ranked #438.
Federation des caisses Desjardins du Quebec first reported a position in BIIB in Q1 2017 and has held it in 38 quarters since. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Federation des caisses Desjardins du Quebec held 31,948 shares of Biogen worth $6.9M as of Q2 2026.
- Federation des caisses Desjardins du Quebec bought 12,367 Biogen shares in Q2 2026, an estimated $2.37M.
- Biogen made up 0.02% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #438 holding.
- Federation des caisses Desjardins du Quebec first reported a position in Biogen in Q1 2017 and has held it in 38 quarters since.
- 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.